研究目的
To advance in the standardization of the retinal vascular tortuosity as a clinical biomarker with diagnostic potential, allowing the validation of objective computational measurements on the basis of the entire spectrum of the expert knowledge.
研究成果
The study highlights the potential of retinal vascular tortuosity as a clinical biomarker but underscores the need for standardization and the incorporation of additional clinical criteria in computational metrics to bridge the gap between automatic effectiveness and expert perception.
研究不足
The lack of a precise and standard guide for tortuosity evaluation, high inter and intra-rater variability, and the absence of clinical criteria in computational measurements.
1:Experimental Design and Method Selection:
A multi-expert validation process was designed to assess computational vascular tortuosity measurements. A group of five experts with different clinical profiles used a four-grade scale and binary classifications for analysis.
2:Sample Selection and Data Sources:
The dataset consisted of 60 fundus images from diabetic patients, varying from non-visible anomalies to severe tortuosity.
3:List of Experimental Equipment and Materials:
Fundus images from diabetic patients were used, with computational metrics for tortuosity assessment.
4:Experimental Procedures and Operational Workflow:
The rating procedure included two rounds of individual expert ratings and a joint consensus session. Computational metrics were applied to the same dataset for comparison.
5:Data Analysis Methods:
Cohen-Kappa indexes were used for intra and inter-rater agreement analysis. ROC analysis was performed to evaluate the prognostic performance of tortuosity metrics.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容